Hepion Pharmaceuticals, Inc.
HEPA
$0.06
-$0.03-35.23%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 59.31% | 19.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.72% | 30.97% | |||
| Operating Income | -51.72% | -30.97% | |||
| Income Before Tax | -53.95% | -23.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -53.95% | -23.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.95% | -23.43% | |||
| EBIT | -51.72% | -30.97% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -10.46% | -23.98% | |||
| Normalized Basic EPS | -10.55% | -30.93% | |||
| EPS Diluted | -10.46% | -23.98% | |||
| Normalized Diluted EPS | -10.55% | -30.93% | |||
| Average Basic Shares Outstanding | 39.35% | -0.49% | |||
| Average Diluted Shares Outstanding | 39.35% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||